{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:30:18Z","timestamp":1786480218116,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2026,6]]},"abstract":"\n Key Points<\/jats:title>\n \n \n \n \n Blood biomarkers related to amyloid\n \u03b2<\/jats:italic>\n and neurofilament light chain are used to predict cognitive decline in the general population.\n <\/jats:p>\n <\/jats:list-item>\n \n Evidence for their usefulness is lacking in patients receiving hemodialysis despite their high risk of cognitive impairment.<\/jats:p>\n <\/jats:list-item>\n \n \n Neurofilament light chain levels were negatively associated with cognitive function, whereas the amyloid\n \u03b2<\/jats:italic>\n ratio was not.\n <\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n \n Cognitive dysfunction is frequently observed in patients undergoing hemodialysis in clinical settings; however, its pathophysiology remains uncertain. In recent years, noninvasive blood biomarkers have garnered increasing attention in predicting Alzheimer's disease development. Within the general population, neurofilament light chain (NfL) levels have been used to prognosticate changes in cognitive function alongside the amyloid\n \u03b2<\/jats:italic>\n (A\n \u03b2<\/jats:italic>\n ) 1\u201342\/1\u201340 ratio. Nevertheless, this has not been studied in patients with CKD, particularly those undergoing hemodialysis.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n This exploratory cross-sectional study investigated the association of the serum A\n \u03b2<\/jats:italic>\n 1\u201342\/1\u201340 ratio and NfL levels with cognitive function assessed using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE), in patients undergoing hemodialysis.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n We included 384 patients with a median age of 74 (interquartile range [IQR], 70\u201380) years. The median (IQR) MoCA and MMSE scores were 25 (22\u201326) and 28 (26\u201329), respectively. The median (IQR) A\n \u03b2<\/jats:italic>\n 1\u201342\/1\u201340 ratio and NfL level were 0.04 (0.03\u20130.06) and 196.2 pg\/ml (146.5\u2013262.2), respectively. The multivariate linear regression analysis indicated a weak negative association between the log-transformed NfL levels and cognitive function, after adjusting for confounding factors including age (\n \u03b2<\/jats:italic>\n coefficient [95% confidence interval], \u22120.98 [\u22121.81 to \u22120.15];\n P<\/jats:italic>\n = 0.021 for MoCA and \u22120.66 [\u22121.32 to \u22120.01];\n P<\/jats:italic>\n = 0.046 for MMSE). However, the A\n \u03b2<\/jats:italic>\n 1\u201342\/1\u201340 ratio was not associated with cognitive function.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Our exploratory analysis identified a weak negative association between serum NfL levels and cognitive function in patients undergoing hemodialysis.<\/jats:p>\n <\/jats:sec>","DOI":"10.34067\/kid.0000001162","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:00:33Z","timestamp":1771606833000},"page":"1307-1315","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Neurofilament Light Chain and Cognitive Dysfunction in Patients Undergoing Hemodialysis"],"prefix":"10.34067","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9197-9434","authenticated-orcid":false,"given":"Kazuhiko","family":"Kato","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan"},{"name":"Division of Molecular Epidemiology, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3730-0301","authenticated-orcid":false,"given":"Akio","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5952-6141","authenticated-orcid":false,"given":"Shunichiro","family":"Shinagawa","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisa","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan"},{"name":"Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Ohkido","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7395-5831","authenticated-orcid":false,"given":"Mitsuyoshi","family":"Urashima","sequence":"additional","affiliation":[{"name":"Division of Molecular Epidemiology, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1838-7998","authenticated-orcid":false,"given":"Takashi","family":"Yokoo","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"7","key":"B1-20260625","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/ndt\/gfx314","article-title":"Prevalence and patterns of cognitive impairment in adult hemodialysis patients: the COGNITIVE-HD study","volume":"33","author":"van Zwieten","year":"2018","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"B2-20260625","doi-asserted-by":"crossref","first-page":"e14408","DOI":"10.15252\/emmm.202114408","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease","volume":"14","author":"Leuzy","year":"2022","journal-title":"EMBO Mol Med."},{"issue":"6","key":"B3-20260625","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat Med."},{"issue":"1","key":"B4-20260625","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol."},{"issue":"12","key":"B5-20260625","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/alz.12756","article-title":"The Alzheimer\u2019s association appropriate use recommendations for blood biomarkers in Alzheimer\u2019s disease","volume":"18","author":"Hansson","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"8","key":"B6-20260625","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"1","key":"B7-20260625","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jalz.2016.09.014","article-title":"Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic","volume":"13","author":"O\u2019Bryant","year":"2017","journal-title":"Alzheimers Dement."},{"issue":"5","key":"B8-20260625","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000338135","article-title":"Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis","volume":"35","author":"Etgen","year":"2012","journal-title":"Am J Nephrol."},{"issue":"11","key":"B9-20260625","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/ckj\/sfad173","article-title":"Plasma A\u03b242:A\u03b240 ratio as a biomarker for cognitive impairment in haemodialysis patients: a multicentre study","volume":"16","author":"Chen","year":"2023","journal-title":"Clin Kidney J."},{"key":"B10-20260625","doi-asserted-by":"crossref","first-page":"657794","DOI":"10.3389\/fnagi.2021.657794","article-title":"The role of plasma neurofilament light protein for assessing cognitive impairment in patients with end-stage renal disease","volume":"13","author":"Hou","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"B11-20260625","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.2147\/IJGM.S368987","article-title":"A profile of nanoparticle-based plasma neurodegenerative biomarkers for cognitive function among patients undergoing hemodialysis","volume":"15","author":"Chen","year":"2022","journal-title":"Int J Gen Med."},{"issue":"11","key":"B12-20260625","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10157-024-02528-0","article-title":"Association between serum magnesium levels and cognitive function in patients undergoing hemodialysis","volume":"28","author":"Kato","year":"2024","journal-title":"Clin Exp Nephrol."},{"issue":"21","key":"B13-20260625","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.3390\/nu16213776","article-title":"Associations of cognitive function with serum magnesium and phosphate in hemodialysis patients: a cross-sectional analysis of the Osaka Dialysis Complication Study (ODCS)","volume":"16","author":"Shoji","year":"2024","journal-title":"Nutrients."},{"issue":"9","key":"B14-20260625","doi-asserted-by":"crossref","first-page":"105702","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105702","article-title":"Cerebral blood flow in chronic kidney disease","volume":"30","author":"Choi","year":"2021","journal-title":"J Stroke Cerebrovasc Dis."},{"issue":"1","key":"B15-20260625","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","article-title":"Elevated neurofilament levels in neurological diseases","volume":"987","author":"Norgren","year":"2003","journal-title":"Brain Res."},{"issue":"1\u20102","key":"B16-20260625","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jim.2009.09.014","article-title":"Neurofilament ELISA validation","volume":"352","author":"Petzold","year":"2010","journal-title":"J Immunol Methods."},{"issue":"2\u20103","key":"B17-20260625","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-1781(00)00232-8","article-title":"Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects","volume":"97","author":"Doi","year":"2000","journal-title":"Psychiatry Res."},{"issue":"4","key":"B18-20260625","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc."},{"issue":"3","key":"B19-20260625","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1447-0594.2010.00585.x","article-title":"Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal cognitive assessment","volume":"10","author":"Fujiwara","year":"2010","journal-title":"Geriatr Gerontol Int."},{"issue":"3","key":"B20-20260625","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res."},{"issue":"3","key":"B21-20260625","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection","volume":"34","author":"VanderWeele","year":"2019","journal-title":"Eur J Epidemiol."},{"issue":"3","key":"B22-20260625","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1744-9987.12058","article-title":"Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder","volume":"17","author":"Fukagawa","year":"2013","journal-title":"Ther Apher Dial."},{"issue":"8","key":"B23-20260625","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"4","key":"B24-20260625","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/00365513.2020.1730434","article-title":"Reference interval and preanalytical properties of serum neurofilament light chain in Scandinavian adults","volume":"80","author":"Hviid","year":"2020","journal-title":"Scand J Clin Lab Invest."},{"issue":"1","key":"B25-20260625","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1681\/ASN.2018050462","article-title":"Investigating the relationship between cerebral blood flow and cognitive function in hemodialysis patients","volume":"30","author":"Findlay","year":"2019","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"B26-20260625","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1212\/WNL.0000000000207419","article-title":"Association of chronic kidney disease with plasma NfL and other biomarkers of neurodegeneration: the H70 birth cohort study in Gothenburg","volume":"101","author":"Dittrich","year":"2023","journal-title":"Neurology."},{"key":"B27-20260625","doi-asserted-by":"crossref","first-page":"1150510","DOI":"10.3389\/fnagi.2023.1150510","article-title":"Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer\u2019s disease","volume":"15","author":"Zhang","year":"2023","journal-title":"Front Aging Neurosci."},{"issue":"12","key":"B28-20260625","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/acn3.51234","article-title":"Blood neurofilament light: a critical review of its application to neurologic disease","volume":"7","author":"Barro","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"issue":"1","key":"B29-20260625","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/acn3.50972","article-title":"Confounding effect of blood volume and body mass index on blood neurofilament light chain levels","volume":"7","author":"Manouchehrinia","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"key":"B30-20260625","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fnagi.2019.00254","article-title":"Role of neurofilament light chain as a potential biomarker for Alzheimer\u2019s disease: a correlative meta-analysis","volume":"11","author":"Jin","year":"2019","journal-title":"Front Aging Neurosci."},{"issue":"3","key":"B31-20260625","doi-asserted-by":"crossref","first-page":"e12614","DOI":"10.1002\/dad2.12614","article-title":"Changes in Alzheimer's disease blood biomarkers in kidney failure before and after kidney transplant","volume":"16","author":"Blankenship","year":"2024","journal-title":"Alzheimers Dement (Amst)."},{"issue":"11","key":"B32-20260625","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","article-title":"Head-to-head comparison of 8 plasma amyloid-\u03b2 42\/40 assays in Alzheimer disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol."},{"issue":"1","key":"B33-20260625","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13195-022-01117-1","article-title":"The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer\u2019s disease: a literature review","volume":"14","author":"Brand","year":"2022","journal-title":"Alzheimers Res Ther."},{"issue":"15","key":"B34-20260625","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.2024.13855","article-title":"Blood biomarkers to detect Alzheimer disease in primary care and secondary care","volume":"332","author":"Palmqvist","year":"2024","journal-title":"JAMA."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:58:35Z","timestamp":1786478315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001162"}},"subtitle":["A Cross-Sectional Exploratory Study"],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000001162","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"2025-11-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}